New Data Show Zometa Increased Bone Mineral Density in Breast
Studies investigating the effect of hormone therapy in the adjuvant treatment of early breast cancer are ongoing and several studies have shown that women receiving long-term treatment with these drugs are at risk of bone loss. Based on the demonstrated effectiveness of aromatase inhibitors, these medicines are increasingly being used as an integral part of the post-surgery treatment protocol for postmenopausal women with hormone sensitive early breast cancer. Femara, in particular, is being used for its proven ability to reduce the risk that breast cancer will come back. Femara is used in both initial adjuvant and extended adjuvant therapy for breast 
· Read The Full Osteonecrosis of the Jaw (ONJ) Article From PharmaLive.com (press release) -->
·
Read All Osteonecrosis of the Jaw (ONJ) News Stories -->